Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: diablo who wrote (205)	12/17/1997 9:23:00 AM
From: Dr. John M. de Castro	Read Replies (2) of 1494

There has been no announcement of delisting. The stock is getting hammered for no apparent reason. IMO, it is a combination of tax loss selling and a fear of delisting. However, lost in the shuffle is the fact that NTII will have results from the Phase II neuropathic pain trial in January. If these results are positive, and I'm very optimistic, NTII is going to flat out soar. I remain long. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next